Article: Ethical Issues Raised Over FDA Collaboration with Biogen on Failed Drug: The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.
By: Peter Simons, May 11, 2021
https://www.madinamerica.com/2021/05/ethical-...iled-drug/
(Someone posted this article on ST today).